Financial Snapshot (Last 12 Months):Market Cap: $125.00M Revenues: $22.50M Net Income: $-33.30M
Alerts: Sign up to get IPO Ratings and Deal Alerts
We are a commercial biomaterial company focused on using our silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. We currently market spinal fusion products and are developing products for use in total hip and knee joint replacements. We believe our silicon nitride, an advanced ceramic, technology platform enables us to offer new and transformative products in the orthopedic and other medical device markets. We believe we are the first and only company to use silicon nitride in medical applications and over 14,000 of our silicon nitride spine products have been implanted in patients.
comments powered by Disqus